|
Model Number NEU_INTERSTIM_INS |
Device Problem
Migration or Expulsion of Device (1395)
|
Patient Problems
Purulent Discharge (1812); Unspecified Infection (1930)
|
Event Type
Injury
|
Manufacturer Narrative
|
Continuation of d10: product id neu_unknown_lead lot# unknown.Product type lead section d information references the main component of the system.Other relevant device(s) are: product id: neu_unknown_lead.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Information was received from multiple sources (manufacturer representative, healthcare provider) regarding a patient who was implan ted with an implantable neurostimulator (ins) for unknown indications for use.It was reported that patient had two basic evaluation leads in place but never contacted field rep or provided a support link to complain of complications, patient never responded to at tempt by field rep prior to lead pull, and patient missed original lead pull appointment.Complications were communicated by the md's nurse practitioner to the field rep on the day of the rescheduled lead pull. email from nurse practitioner during dressing removal , odorous purulent drainage expressed from the basic evaluation lead site, cultures taken, 4x6cm area of firmness noted, pt placed on antibiotic, and follow-up scheduled. pt has a follow-up on friday, (b)(6) 2024.
|
|
Event Description
|
Additional information was received from a manufacturer representative (rep).The rep reported that the patient was seen again today.Their ct showed an ill-defined collection but no well marinated abscess.Cx positive for staph-treated with clina.Approximately 50% better today.The hcp wants a ct repeated and to add bactrim to coverage.Rep noted they will update as this occurs.
|
|
Manufacturer Narrative
|
Product id neu_unknown_lead lot# unknown serial# implanted: explanted: product type lead medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Additional information was received from a manufacturer representative (rep).The rep reported that the previously noted inflammation involving the left buttock musculature was much improved with only minor superficial edema at the site.There was no definable fluid collection or abscess.Continued clinical follow-up was advised.The area was free of erythema, nontender, no longer open, and had no drainage.The patient was asking how soon they could proceed with the implant.
|
|
Search Alerts/Recalls
|
|
|